Daria Jacob

Title: Daria Jacob - Innovator in Vaccine Technology

Introduction

Daria Jacob is a prominent inventor based in Paris, France. She has made significant contributions to the field of vaccine technology, particularly through her innovative research and development of subunit vaccine platforms. Her work focuses on utilizing multimeric ribonucleoproteins as carriers for heterologous polypeptides, which has the potential to enhance immunogenic responses.

Latest Patents

Daria Jacob holds a patent for a subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides. This invention relates to the assembly of at least 200 fusion proteins with cellular RNA, or to recombinant yeasts or yeast lysates expressing these multimeric ribonucleoproteins. The patent also outlines a process for preparing these multimeric ribonucleoproteins or recombinant yeasts, emphasizing their use in producing immunogenic compositions and eliciting protective immune responses.

Career Highlights

Throughout her career, Daria has worked with esteemed institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. Her research has been pivotal in advancing the understanding of vaccine development and its applications in immunology.

Collaborations

Daria has collaborated with notable professionals in her field, including her coworker Monica Sala, who has contributed to various projects alongside her.

Conclusion

Daria Jacob's innovative work in vaccine technology exemplifies the impact of scientific research on public health. Her contributions continue to pave the way for advancements in immunization strategies and therapeutic responses.